
Neurocrine Biosciences Presents 48-Week Remission Data On Treatment Of Tardive Dyskinesia With INGREZZA® (Valbenazine) ...
(MENAFN- PR Newswire) Majority of Participants Reached a Defined Threshold for Remission of Tardive Dyskinesia Regardless of Underlying Psychiatric Disorder Findings Presented at the 2025 Psychiatry Update Conference SAN DIEGO, March 20, 2025 / …